Current and emerging treatment options for spinal cord ischemia
•Spinal cord ischemia is a rare but disabling disorder.•We summarize current and emerging treatment concepts.•There is a lack of randomized controlled trials.•Several neuroprotective treatment options await translational adoption. Spinal cord infarction (SCI) is a rare but disabling disorder caused...
Gespeichert in:
| Veröffentlicht in: | Drug discovery today 2016-10, Vol.21 (10), p.1632-1641 |
|---|---|
| Hauptverfasser: | , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 1641 |
|---|---|
| container_issue | 10 |
| container_start_page | 1632 |
| container_title | Drug discovery today |
| container_volume | 21 |
| creator | Nardone, Raffaele Pikija, Slaven Mutzenbach, J. Sebastian Seidl, Martin Leis, Stefan Trinka, Eugen Sellner, Johann |
| description | •Spinal cord ischemia is a rare but disabling disorder.•We summarize current and emerging treatment concepts.•There is a lack of randomized controlled trials.•Several neuroprotective treatment options await translational adoption.
Spinal cord infarction (SCI) is a rare but disabling disorder caused by a wide spectrum of conditions. Given the lack of randomized-controlled trials, contemporary treatment concepts are adapted from guidelines for cerebral ischemia, atherosclerotic vascular disease, and acute traumatic spinal cord injury. In addition, patients with SCI are at risk for several potentially life-threatening but preventable systemic and neurologic complications. Notably, there is emerging evidence from preclinical studies for the use of neuroprotection in acute ischemic injury of the spinal cord. In this review, we discuss the current state of the art for the therapy and prevention of SCI and highlight potential emerging treatment concepts awaiting translational adoption.
Spinal cord infarction is a rare but often devastating condition. Here, we discuss emerging treatment concepts awaiting translational adoption. |
| doi_str_mv | 10.1016/j.drudis.2016.06.015 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1826700938</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1359644616302331</els_id><sourcerecordid>1826700938</sourcerecordid><originalsourceid>FETCH-LOGICAL-c428t-8bf4185340b7752c9d6d32edf49073460b089630ad98f211c39d6242182e012a3</originalsourceid><addsrcrecordid>eNp9kElLxDAUx4Mozjj6DUR69NKarWl6UWRwgwEveg5p8jpm6GbSCn57M3T0KDx4C7-3_RG6JDgjmIibXWb9ZF3IaMwyHI3kR2hJZCHTXDJ6HGOWl6ngXCzQWQg7jAktc3GKFrRgVJQEL9HdevIeujHRnU2gBb913TYZPeix3Zf7YXR9F5K690kYXKebxPTeJi6YD2idPkcntW4CXBz8Cr0_Prytn9PN69PL-n6TGk7lmMqq5kTmjOOqKHJqSisso2BrXuKCcYErLEvBsLalrCkhhkWCckokhXi1Zit0Pc8dfP85QRhVG0-AptEd9FNQERQFxiWTEeUzanwfgodaDd612n8rgtVeOrVTs3RqL53C0Uge264OG6aqBfvX9KtVBG5nAOKfXw68CsZBZ8A6D2ZUtnf_b_gBZqqACQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1826700938</pqid></control><display><type>article</type><title>Current and emerging treatment options for spinal cord ischemia</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Nardone, Raffaele ; Pikija, Slaven ; Mutzenbach, J. Sebastian ; Seidl, Martin ; Leis, Stefan ; Trinka, Eugen ; Sellner, Johann</creator><creatorcontrib>Nardone, Raffaele ; Pikija, Slaven ; Mutzenbach, J. Sebastian ; Seidl, Martin ; Leis, Stefan ; Trinka, Eugen ; Sellner, Johann</creatorcontrib><description>•Spinal cord ischemia is a rare but disabling disorder.•We summarize current and emerging treatment concepts.•There is a lack of randomized controlled trials.•Several neuroprotective treatment options await translational adoption.
Spinal cord infarction (SCI) is a rare but disabling disorder caused by a wide spectrum of conditions. Given the lack of randomized-controlled trials, contemporary treatment concepts are adapted from guidelines for cerebral ischemia, atherosclerotic vascular disease, and acute traumatic spinal cord injury. In addition, patients with SCI are at risk for several potentially life-threatening but preventable systemic and neurologic complications. Notably, there is emerging evidence from preclinical studies for the use of neuroprotection in acute ischemic injury of the spinal cord. In this review, we discuss the current state of the art for the therapy and prevention of SCI and highlight potential emerging treatment concepts awaiting translational adoption.
Spinal cord infarction is a rare but often devastating condition. Here, we discuss emerging treatment concepts awaiting translational adoption.</description><identifier>ISSN: 1359-6446</identifier><identifier>EISSN: 1878-5832</identifier><identifier>DOI: 10.1016/j.drudis.2016.06.015</identifier><identifier>PMID: 27326910</identifier><language>eng</language><publisher>England: Elsevier Ltd</publisher><subject>Animals ; Humans ; Neuroprotective Agents - therapeutic use ; Prognosis ; Spinal Cord Ischemia - drug therapy ; Spinal Cord Ischemia - etiology ; Spinal Cord Ischemia - prevention & control</subject><ispartof>Drug discovery today, 2016-10, Vol.21 (10), p.1632-1641</ispartof><rights>2016 Elsevier Ltd</rights><rights>Copyright © 2016 Elsevier Ltd. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c428t-8bf4185340b7752c9d6d32edf49073460b089630ad98f211c39d6242182e012a3</citedby><cites>FETCH-LOGICAL-c428t-8bf4185340b7752c9d6d32edf49073460b089630ad98f211c39d6242182e012a3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.drudis.2016.06.015$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,777,781,3537,27905,27906,45976</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/27326910$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Nardone, Raffaele</creatorcontrib><creatorcontrib>Pikija, Slaven</creatorcontrib><creatorcontrib>Mutzenbach, J. Sebastian</creatorcontrib><creatorcontrib>Seidl, Martin</creatorcontrib><creatorcontrib>Leis, Stefan</creatorcontrib><creatorcontrib>Trinka, Eugen</creatorcontrib><creatorcontrib>Sellner, Johann</creatorcontrib><title>Current and emerging treatment options for spinal cord ischemia</title><title>Drug discovery today</title><addtitle>Drug Discov Today</addtitle><description>•Spinal cord ischemia is a rare but disabling disorder.•We summarize current and emerging treatment concepts.•There is a lack of randomized controlled trials.•Several neuroprotective treatment options await translational adoption.
Spinal cord infarction (SCI) is a rare but disabling disorder caused by a wide spectrum of conditions. Given the lack of randomized-controlled trials, contemporary treatment concepts are adapted from guidelines for cerebral ischemia, atherosclerotic vascular disease, and acute traumatic spinal cord injury. In addition, patients with SCI are at risk for several potentially life-threatening but preventable systemic and neurologic complications. Notably, there is emerging evidence from preclinical studies for the use of neuroprotection in acute ischemic injury of the spinal cord. In this review, we discuss the current state of the art for the therapy and prevention of SCI and highlight potential emerging treatment concepts awaiting translational adoption.
Spinal cord infarction is a rare but often devastating condition. Here, we discuss emerging treatment concepts awaiting translational adoption.</description><subject>Animals</subject><subject>Humans</subject><subject>Neuroprotective Agents - therapeutic use</subject><subject>Prognosis</subject><subject>Spinal Cord Ischemia - drug therapy</subject><subject>Spinal Cord Ischemia - etiology</subject><subject>Spinal Cord Ischemia - prevention & control</subject><issn>1359-6446</issn><issn>1878-5832</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kElLxDAUx4Mozjj6DUR69NKarWl6UWRwgwEveg5p8jpm6GbSCn57M3T0KDx4C7-3_RG6JDgjmIibXWb9ZF3IaMwyHI3kR2hJZCHTXDJ6HGOWl6ngXCzQWQg7jAktc3GKFrRgVJQEL9HdevIeujHRnU2gBb913TYZPeix3Zf7YXR9F5K690kYXKebxPTeJi6YD2idPkcntW4CXBz8Cr0_Prytn9PN69PL-n6TGk7lmMqq5kTmjOOqKHJqSisso2BrXuKCcYErLEvBsLalrCkhhkWCckokhXi1Zit0Pc8dfP85QRhVG0-AptEd9FNQERQFxiWTEeUzanwfgodaDd612n8rgtVeOrVTs3RqL53C0Uge264OG6aqBfvX9KtVBG5nAOKfXw68CsZBZ8A6D2ZUtnf_b_gBZqqACQ</recordid><startdate>201610</startdate><enddate>201610</enddate><creator>Nardone, Raffaele</creator><creator>Pikija, Slaven</creator><creator>Mutzenbach, J. Sebastian</creator><creator>Seidl, Martin</creator><creator>Leis, Stefan</creator><creator>Trinka, Eugen</creator><creator>Sellner, Johann</creator><general>Elsevier Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>201610</creationdate><title>Current and emerging treatment options for spinal cord ischemia</title><author>Nardone, Raffaele ; Pikija, Slaven ; Mutzenbach, J. Sebastian ; Seidl, Martin ; Leis, Stefan ; Trinka, Eugen ; Sellner, Johann</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c428t-8bf4185340b7752c9d6d32edf49073460b089630ad98f211c39d6242182e012a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>Animals</topic><topic>Humans</topic><topic>Neuroprotective Agents - therapeutic use</topic><topic>Prognosis</topic><topic>Spinal Cord Ischemia - drug therapy</topic><topic>Spinal Cord Ischemia - etiology</topic><topic>Spinal Cord Ischemia - prevention & control</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Nardone, Raffaele</creatorcontrib><creatorcontrib>Pikija, Slaven</creatorcontrib><creatorcontrib>Mutzenbach, J. Sebastian</creatorcontrib><creatorcontrib>Seidl, Martin</creatorcontrib><creatorcontrib>Leis, Stefan</creatorcontrib><creatorcontrib>Trinka, Eugen</creatorcontrib><creatorcontrib>Sellner, Johann</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Drug discovery today</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Nardone, Raffaele</au><au>Pikija, Slaven</au><au>Mutzenbach, J. Sebastian</au><au>Seidl, Martin</au><au>Leis, Stefan</au><au>Trinka, Eugen</au><au>Sellner, Johann</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Current and emerging treatment options for spinal cord ischemia</atitle><jtitle>Drug discovery today</jtitle><addtitle>Drug Discov Today</addtitle><date>2016-10</date><risdate>2016</risdate><volume>21</volume><issue>10</issue><spage>1632</spage><epage>1641</epage><pages>1632-1641</pages><issn>1359-6446</issn><eissn>1878-5832</eissn><abstract>•Spinal cord ischemia is a rare but disabling disorder.•We summarize current and emerging treatment concepts.•There is a lack of randomized controlled trials.•Several neuroprotective treatment options await translational adoption.
Spinal cord infarction (SCI) is a rare but disabling disorder caused by a wide spectrum of conditions. Given the lack of randomized-controlled trials, contemporary treatment concepts are adapted from guidelines for cerebral ischemia, atherosclerotic vascular disease, and acute traumatic spinal cord injury. In addition, patients with SCI are at risk for several potentially life-threatening but preventable systemic and neurologic complications. Notably, there is emerging evidence from preclinical studies for the use of neuroprotection in acute ischemic injury of the spinal cord. In this review, we discuss the current state of the art for the therapy and prevention of SCI and highlight potential emerging treatment concepts awaiting translational adoption.
Spinal cord infarction is a rare but often devastating condition. Here, we discuss emerging treatment concepts awaiting translational adoption.</abstract><cop>England</cop><pub>Elsevier Ltd</pub><pmid>27326910</pmid><doi>10.1016/j.drudis.2016.06.015</doi><tpages>10</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1359-6446 |
| ispartof | Drug discovery today, 2016-10, Vol.21 (10), p.1632-1641 |
| issn | 1359-6446 1878-5832 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_1826700938 |
| source | MEDLINE; Elsevier ScienceDirect Journals |
| subjects | Animals Humans Neuroprotective Agents - therapeutic use Prognosis Spinal Cord Ischemia - drug therapy Spinal Cord Ischemia - etiology Spinal Cord Ischemia - prevention & control |
| title | Current and emerging treatment options for spinal cord ischemia |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-19T10%3A49%3A03IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Current%20and%20emerging%20treatment%20options%20for%20spinal%20cord%20ischemia&rft.jtitle=Drug%20discovery%20today&rft.au=Nardone,%20Raffaele&rft.date=2016-10&rft.volume=21&rft.issue=10&rft.spage=1632&rft.epage=1641&rft.pages=1632-1641&rft.issn=1359-6446&rft.eissn=1878-5832&rft_id=info:doi/10.1016/j.drudis.2016.06.015&rft_dat=%3Cproquest_cross%3E1826700938%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1826700938&rft_id=info:pmid/27326910&rft_els_id=S1359644616302331&rfr_iscdi=true |